Drug shortage means prescribers asked to switch treatment for acute respiratory problems in COVID-19 patients

0
137

[ad_1]

A shortage of the drug methylprednisolone to support “business as usual” has led to organisations being asked to stop prescribing it for the treatment of acute respiratory distress syndrome in patients with COVID-19.

[ad_2]

Source link

Share and Enjoy !

0Shares
0 0